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Abstract
Introduction. This study endeavors to analyze the effects of miR-1204 on the expression of DEK oncogene in 
non-small cell lung cancer (NSCLC) cell lines and to study the molecular mechanisms of these effects. 
Material and methods. The miR-1204 mimics and inhibitors were transfected into the (A549 and SPC) NSCLC 
cells. Then the mRNA levels, cell viability, apoptosis rate, morphology and caspase activity were determined. 
The expression of apoptosis-related proteins Bcl-2 and Bax was also analyzed.
Results. In NSCLC cell lines (A549 and SPC), DEK mRNA levels were down-regulated in miR-1204 overex-
pression group. In miR-1204 inhibition group, the expression of DEK mRNA showed an opposite trend. The 
overexpression of miR-1204 increases the apoptosis rate in NSCLC cells. The Bcl-2 level in the miR-1204 over-
expression group was decreased, while the Bax level was increased. In the miR-1204 inhibition group, expression 
of Bcl-2 and Bax showed opposite trends. Cell staining revealed cell’s morphological changes; the apoptosis in 
the miR-1204 overexpression group revealed significant morphological features, such as brighter nuclei and nu-
clear condensation. Results indicated a typical characteristic of apoptosis in the miR-1204 overexpression group. 
Caspase-9 and Caspase-3 were involved in the apoptosis pathway, which was mediated by miR-1204 and DEK.
Conclusions. The miR-1204 induces apoptosis of NSCLC cells by inhibiting the expression of DEK. The mech-
anism of apoptosis involves down-regulation of Bcl-2 and up-regulation of Bax expression. Moreover, the apo-
ptosis was mediated by mitochondria-related caspase 9/3 pathway. (Folia Histochemica et Cytobiologica 2019, 
Vol. 57, No. 2, 64–73)
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Introduction
Lung cancer is the leading cause of cancer-related 
death worldwide. More than one million cases are 
diagnosed each year [1]. Lung cancer is morphologi-
cally divided into non-small cell lung cancer (NSCLC) 
and small cell lung cancer, of which NSCLC accounts 
for about 80% of all lung cancer cases [2]. Despite 
the growing number of NSCLC genomics studies 
and targeted therapies, the overall 5-year survival 
rate is only 15% [3, 4]. This highlights the need for 
a better understanding of NSCLC biology to improve 
the prevention, diagnosis and treatment of this can-
cer [5]. Recently, there is evidence that microRNAs 
(miRNAs) may be involved in the pathogenesis of 
NSCLC, providing new insights into disease biology.
DEK oncogene (DEK) is a ubiquitous protein 
in multicellular organisms and some single-celled 
organisms. DEK can promote the repair of DNA 
damage while also participates in apoptosis [6]. DEK 
has been already identified as an oncogene and is 
overexpressed in various malignant tumors, such as 
colorectal, gastric, neuroendocrine, prostate, breast, 
and bladder cancer [7–11]. Recent studies indicate 
that DEK depletion induced astrocytic tumor cell ap-
optosis with down-regulated expression of Bcl-2 and 
C-myc; the caspase-3 activity in the astrocytic tumor 
was also significantly enhanced after the knockdown 
[12]. Data indicate that DEK plays multiple roles 
such as promotion of proliferation and migration of 
cancer cells and facilitation of tumor growth and its 
maintenance [13]. It can be used as a potential target 
for astrocytic tumor diagnosis and gene therapy [14]. 
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DEK overexpression is an important independent risk 
factor for overall survival in patients with NSCLC. 
DEK may potentially be used as an independent 
biomarker for NSCLC prognosis assessment [15].
MicroRNAs (miRNAs) are a class of endogenous 
non-coding RNAs of approximately 20–24 nucleo-
tides. MiRNAs play important roles in a variety of 
cellular processes including proliferation, apoptosis, 
differentiation, and malignant transformation [13–18]. 
New evidence has revealed that miRNAs influence 
the initiation and progression of various malignan-
cies, including lung cancer [19–21]. For example, 
it is reported that miR-145, miR-21, miR-214, and 
miR-29c have a crucial role in lung cancer [22–25]. 
miR-1204 is a member of the PVT1 region. Recent 
studies have found that miR-1204 may improve B cell 
differentiation and metastasis in breast cancer and 
can target PITX1 in NSCLC, which may be a poor 
prognostic factor and a potential therapeutic target 
for NSCLC [26].
The aim of this study is to find out if miR-1204 tar-
geting DEK in A549 and SPC cells affects cell apoptosis 
and apoptosis-related pathways by transfecting the cells 
with miR-1204 or miR-1204 inhibitors. To examine 
the potential molecular mechanisms of miR-1204 on 
apoptosis, we assayed the expression of apoptosis-re-
lated proteins (Bcl-2 and Bax), activity of caspase-3, 
caspase-8, and caspase-9, cell morphology and other 
biological behaviors of NSCLC cells and explored their 
related mechanisms.
Materials and methods
Cell cultures. The A549 and SPC cell lines of NSCLC were 
purchased from the American Type Culture Collection 
(Manassas, VA, USA). The cells were maintained in the 
Dulbecco’s Modified Eagle Medium (DMEM) with 10% fe-
tal bovine serum (FBS), 100 U/ml penicillin, and 100 mg/ml 
streptomycin in humidified air with 5% CO2 at 37°C. 
miRNA target gene prediction databases. Three miRNA 
target gene prediction databases were used in research. 
miRanda: http://www.microrna.org/; TargetScan: http://www.
targetscan.org/; miRWalk:http://zmf.umm.uni-heidelberg.de/
The miRNA mimics, siRNAs, cell transfection, and lucif-
erase reporter assays. The miR-1204 mimic, miR-1204 
inhibitor, control miRNA, DEK siRNA (si-DEK), and 
control siRNA (si-Control) were obtained from RiboBio 
(Guangzhou, China). The A549 and SPC cells were trans-
fected with miR-1204 mimics, miR-1204 inhibitors, control 
miRNA, DEK siRNA, and control siRNA (50 nM) using 
riboFECT™ CP transfection (RiboBio) following the man-
ufacturer’s instructions. 
The 3’-UTR of the DEK gene containing the putative 
binding sites for miR-1204 was infused into a pGL vector 
purchased from Hai Chuang Biological Technology Co. 
(Beijing, China). Cells were calibrated into 24-well plates 
and cotransfected with miR-1204 mimics, miR-1204 in-
hibitors, or control miRNA with 0.8 µg luciferase reporter 
plasmids, or control reporter vectors. Luciferase activity was 
measured after 48 h of transfection using a dual-luciferase 
assay system (#E2920; Promega, Madison, WI, USA). Re-
sults were normalized to Renilla luciferase activity.
Real-time RT-PCR. Total RNA was extracted from 
NSCLC cells using Trizol reagent (Invitrogen, Carlsbad, 
CA, USA). The expression of miR-1204 was evaluated 
with miDETECT, a Track TMmiRNA qRT-PCR Starter 
Kit (RiboBio). Real-time PCR was conducted using the 
GoTaq Real-Time PCR Systems (Promega) to evaluate 
the DEK expression. B2M level was used as a control for 
the real-time PCR analysis. The primers for B2M were: 
sense, 5’-GGCTATCCAGCGTACTCC-3’; anti-sense, 
5’-ACGGCAGGCATACTCATC-3’. Primers for DEK 
were: sense, 5’-TGTTAAGAAAGCAGATAGCAG-
CACC-3’; anti-sense 5’-ATTAAAGGTTCATCATCT-
GAACTATCCTC-3’. The primers for Bcl-2 were: sense, 
5’-GGCTATCCAGCGTACTCC-3’; anti-sense 5’-ACGG-
CAGGCATACTCATC-3’. The primers for Bax were: 
sense, 5’-GGAGCTGCAGAGGATGATTG-3’; anti-sense, 
5’-CCTCCCAGAAAAATGCCATA -3’. The results were 
analyzed by the following formula: 2-DDCt.
Cell viability assay. The cells were seeded into 96-well plates 
(3 × 104 cells/well) and evaluated for 10–60 h after transfec-
tion. The process was repeated thrice in each group. The cell 
viability was determined by the addition of Cell Counting 
Kit-8 (MedChem Express, Beijing, China). The CCK-8 kit, 
based on the chemical reactivity of WST-8 (2-(2-methoxy-4- 
-nitro))-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetra-
zole monosodium salt), is a rapid and highly sensitive kit 
widely used for the assessment of cell proliferation and 
cytotoxicity. WST-8 belongs to the upgraded product of 
MTT. In the presence of electron coupling reagent WST-8 
can be reduced by mitochondrial dehydrogenases to produce 
highly water-soluble orange-yellow formazan product. Cell 
proliferation is proportional and inversely proportional to 
cytotoxicity. The OD value was measured at a wavelength 
of 450 mm using a microplate reader (TECAN, Vienna, 
Austria), indirectly reflecting the number of viable cells. 
Analysis of cell apoptosis. Annexin V-FITC/PI kit (Keygen 
Biotech, Jiangsu, China) was used to assay the apoptosis. 
The cells were collected after 48 hours of transfection in 
accordance with the manufacturer’s instructions. Later, the 
cells were incubated with Annexin V — fluorescein isothi-
ocyanate and propidium iodide for 15 min in the dark at 
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25°C to analyze the percentage of apoptotic cells. Cells were 
analyzed with a FACS Calibur flow cytometer (NovoCyte, 
Beijing, China). 
Assessment of cell morphology. The cells were assayed after 
48 h of transfection and stained with Hoechst 33258 (10 mg/ml) 
for 20 min at 37°C. Later, after washing the cells with phos-
phate-buffered saline (PBS), the morphology of the cells was 
monitored and photographed under TE-2000S fluorescence 
microscope (Nikon, Tokyo, Japan).
Caspase activity assay. The cells (2 ×) were seeded in 
6-well plates and collected 48 h after transfection. The 
cells were treated according to the protocol described, with 
Caspase-3, -8, and -9 Fluorescence Assay Kits (Biovision, 
San Francisco, CA, USA). The activities of caspase-3, -8, and 
-9 were measured using a fluorescence spectrophotometer 
(BMG LABTECH, Baden, Stuttgart, Germany) with an 
excitation wavelength of 400 nm and emission wavelength 
of 505 nm. 
Statistical analysis. Statistical analysis was carried out 
using the SPSS version 2.0 (IBM, Armonk, NY, USA). 
Differences between two groups were enumerated using 
the two-tailed Student’s t-tests. P < 0.05 was considered to 
illustrate a statistically significant difference, and all values 
were expressed as mean ± SEM. 
Results
The prediction of DEK as a target of miR-1204
Earlier results from the sequencing analysis had 
indicated that there were large numbers of differen-
tially expressed sequences between the DEK silencing 
group and the DEK silencing control group in A549 
lung cancer cells, especially the miRNA sequences. 
Hence, it was reasonably presumed that DEK might 
be regulated by miRNA. 
Three miRNA target gene prediction databases 
(miRanda, TargetScan, and miRWalk) were applied 
to predict the potential binding sites of miR-1204, 
where DEK was the target gene (Fig. 1). 
The miR-1204 overexpression and inhibition
The study was successful in detecting the expression 
level of miR-1204, 48 hours after transfection with 
miR-1204 mimic, inhibitor, or corresponding control 
respectively in A549 or SPC cells. The level of expres-
sion of miR-1204 in the miR-1204 mimic group was 
significantly higher than that in the control group, 
while the expression level of miR-1204 in miR-1204 
inhibitor group was apparently lower than that in the 
control group (Fig. 2A). 
The miR-1204 inhibits the activity of DEK 3’-UTR
DEK 3’-UTR luciferase reporter plasmid was 
co-transfected with miR-1204 mimic, inhibitor, or 
corresponding control, respectively, into A549 or SPC 
cells. After transfection for 48 hours, the cells were 
collected and the luciferase activity was measured. 
The luciferase activity of A549 and SPC cells transfect-
ed with DEK 3’ -UTR encoding plasmid was observed 
to have been decreased in miR-1204 overexpression 
group. Meanwhile, the luciferase activity with DEK 
3’-UTR encoding plasmid was found to have been 
increased in the miR-1240 inhibition group (Fig. 2B). 
The miR-1204 inhibits DEK expression
The miR-1204 mimic, inhibitor, and the correspond-
ing control were transfected in A549 and SPC cells. 
Thereafter, the DEK mRNA level was examined 
through the RT-PCR analysis. The resultant data 
indicated a decrease of DEK expression in the miR-
1204 overexpression group when compared with the 
control group, whereas the DEK expression in the 
miR-1204 inhibition group indicated an opposite 
trend (Fig. 2C). 
The miR-1204 overexpression increases apoptosis 
in NSCLC cells
To substantiate the premise that miR-1204 regulates 
apoptosis in NSCLC cells, we transfected miR-1204 
mimic, inhibitor, or the corresponding control, re-
spectively, into A549 and SPC cells, and measured the 
apoptosis rate using the flow cytometer. The apoptosis 
rate in miR-1204 overexpression group was found to 
have significantly increased, while it had decreased in 
the miR-1204 inhibition group (Fig. 3A–D). 
By using Hoechst 333258 staining technique, we 
observed the changes in the cell morphology with 
a fluorescence microscope. The miR-1204 overex-
pression group revealed characteristic morphological 
features of apoptosis such as brighter nuclei and 
nuclear condensation (Fig. 3E–F).
The miR-1204 inhibits proliferation of NSCLC cells
The CCK-8 assay showed that miR-1204 inhibited 
the proliferation of NSCLC cells. We transfected 
miR-1204 mimic, inhibitor, or corresponding control 
into A549 and SPC cells, and the cell viability was 
DEK 3’-UTR 802-826  5’
hsa-miR-1204  3’ AUAAGGGAGACCAaggccacga
AGUAUUAACUCUGUaaaagugug 3’
5’
Figure 1. Complementarity site for miR-1204 in the 3’-UTR 
region of DEK
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determined after 10–60 h. It was found that miR-1204 
significantly inhibited the proliferation of NSCLC 
cells and that the inhibitory effect of miR-1204 was 
time-dependent (Fig. 4).
Effect of siDEK on expression of Bcl-2 and Bax
We transfected A549 and SPC cells with siDEK or 
control, and then detected mRNA expression levels 
of Bcl-2 and Bax. It was demonstrated that Bcl-2 
Figure 2. miR-1204 overexpression and inhibition in A549 and SPC cells. A. Real-time RT-PCR detection of miR-1204 ex-
pression in A549 and SPC cells transfected with miR-1204 mimic (mimic, inhibitor or corresponding controls). B. Luciferase 
activity in A549 and SPC cells transfected with DEK 3’-UTR luciferase reporter plasmid and miR-1204 mimic (mimic, inhib-
itor or corresponding controls). C. Detection of DEK mRNA expression in A549 and SPC cells transfected with miR-1204 
mimic (mimic, inhibitor or corresponding controls) by real-time RT-PCR. *P < 0.05, **P < 0.01 compared with mimic or 
inhibitor control transfected cells. Data are presented as the mean ± SEM of three independent experiments. 
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Figure 3. miR-1204 induced apoptosis in A549 and SPC cells. A. A549 cells apoptosis was detected by flow cytometry. Num-
bers 1–5 represent the A549, miR-1204 mimic, miR-1204 mimic control, miR-1204 inhibitor, miR-1204 inhibitor control. 
B. Apoptosis rate in A549 cells after transfected with miR-1204 mimic (mimic, inhibitor or corresponding controls). C. SPC 
cells apoptosis was detected by flow cytometry. Numbers 1–5 represent the SPC, miR-1204 mimic, miR-1204 mimic control, 
miR-1204 inhibitor, miR-1204 inhibitor control. D. Apoptosis rate in SPC cells after transfected with miR-1204 mimic (mim-
ic, inhibitor or corresponding controls). *P < 0.05, **P < 0.01 compared with mimic or inhibitor control transfected cells. 
Data are presented as the mean± SEM of three independent experiments. E. Nuclear morphology was observed in A549 
cells by Hoechst 33258 staining. Numbers 1–5 represent the A549, miR-1204 mimic, miR-1204 mimic control, miR-1204 
inhibitor, miR-1204 inhibitor control (scale bars: 100 µm). F. Nuclear morphology was observed in SPC cells by Hoechst 
33258 staining. Numbers 1–5 represent the SPC, miR-1204 mimic, miR-1204 mimic control, miR-1204 inhibitor, miR-1204 
inhibitor control. Apoptotic cells with bright, nuclear condensation. Scale bars: 100 µm.
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expression was significantly decreased in siDEK 
group compared with the control group, while Bax 
expression was significantly increased (Fig. 5A–C). 
Effects of miR-1204 on the expression of Bcl-2  
and Bax
The miR-1204 mimic, inhibitor, or corresponding 
control were transfected into A549 and SPC cells and 
the mRNA expression levels of Bcl-2 and Bax were 
determined. The Bcl-2 expression was significantly 
decreased in the miR-1204 overexpression group 
compared with the control group, while the Bax ex-
pression was significantly increased. In the miR-1204 
inhibition group, the opposite results were observed 
(Fig. 6A, B). 
Activation of caspase-3, caspase-8, and caspase-9 
during miR-1204-induced apoptosis
The activation of caspases in miR-1204 induced cell 
apoptosis were investigated sequentially. As Figure 7 
shows, in the both cell lines, A549 and SPC, caspase-3 
activity increased in the miR-1204 overexpression 
group. Caspase-9 activity was also observed to have in-
creased. However, no change in caspase-8 activity was 
detected in any of the cell groups tested (Fig. 7A, B).
Discussion
miR-1204 is a member of the PVT1 region. Recent 
studies have found that miR-1204 may improve B cell 
differentiation and metastasis in breast cancer and 
can target PITX1 in non-small cell lung cancer, which 
may be a poor prognostic factor and a potential thera-
peutic target for NSCLC [26]. We used three miRNA 
target prediction databases (miRanda, TargetScan, 
and miRWalk) to determine the target gene of miR-
1204. It was found that one target gene of miR-1204 
was DEK. The DEK overexpression is prevalent in 
numerous types of malignant cancers [7–8]. Recently, 
many studies have found DEK to be carcinogenic in 
lung cancer formation [9–11]. However, there is very 
little research on the role of microRNA in DEK. 
Hence, we proposed the hypothesis that the expres-
sion of DEK could be regulated by miR-1204. With 
an intent to confirm this hypothesis, first, we used 
luciferase reporter assay to confirm DEK as a target 
gene of miR-1204. Moreover, we also found that the 
mRNA levels of DEK were negatively correlated 
with the expression of miR-1204. The above results 
provided evidence to substantiate the hypothesis that 
the expression of DEK in NSCLC was negatively 
regulated by miR-1204. 
Next, to reveal the effects of the miR-1204 on 
NSCLC cells by regulating DEK, the effect of miR-
1204 on apoptosis of A549 and SPC cells were inves-
tigated. The apoptosis is a programmed cell death 
and an important physiological process to maintain 
homeostasis [27]. Alterations of the apoptosis play 
a significant role in the survival of abnormal cells and 
tumorigenesis [28, 29]. Cell apoptosis is characterized 
by chromatin concentration, DNA fragmentation, 
membrane foaming, and/or apoptotic bodies [25–30]. 
In our study, Annexin V FITC analysis of flow cy-
tometry and in vitro Hochest 33258 staining analysis 
indicated that the apoptosis rate of A549 and SPC 
cells in miR-1204 overexpression group was increased, 
while the apoptosis rate was found to have decreased 
in the miR-1204 inhibited group. The cell viability of 
the miR-1204 overexpression group was significantly 
lower than that of the control group, whereas, the 
Figure 4. Cell proliferation of A549 and SPC. Cells were transfected with miR-1204 mimic or miR-1204 mimic control and 
measured by CCK-8 assays. The absorbance was measured at 450 nm as described in Methods.
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miR-1204 inhibited group expressed an opposite 
trend. These results evidenced that miR-1204 over-
expression induced apoptosis in A549 and SPC cells 
and inhibited their growth. 
Apoptosis is strictly regulated by the multiple 
pathways and proteins. The members of the Bcl-2 
family play a crucial role in inhibiting or promoting 
apoptosis [31]. The Bcl-2 family consists of anti-ap-
optotic (Bcl-2, Bcl-w, Bcl-xl, A1) and pro-apoptotic 
molecules (Bax, Bcl-xs, Bad, Bak, Bid, Bim, Bik) [12, 
31]. Bax protein allows some ions and small molecules 
such as cytochrome C to penetrate the mitochondrial 
Figure 5. Expression of Bcl-2 and Bax affected by siRNA DEK. A. Real-time RT-PCR detection of DEK expression in A549 
and SPC cells transfected with siDEK or controls. B. Real-time RT-PCR detection of Bcl-2 expression in A549 and SPC cells 
transfected with siDEK or controls. C. Real-time RT-PCR detection of Bax expression in A549 and SPC cells transfected 
with siDEK or controls. *P < 0.05, **P < 0.01 compared with control group of transfected cells. Data are presented as the 
mean ± SEM of three independent experiments. 
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Figure 6. Expression of Bcl-2 and Bax affected by miR-1204. A. Bcl-2 and Bax mRNA expression in A549 cells transfected 
with miR-1204 mimic (mimic, inhibitor or corresponding controls) was detected by real-time PCR. B. Bcl-2 and Bax mRNA 
expression in SPC cells transfected with miR-1204 mimic (mimic, inhibitor or corresponding controls) was detected by re-
al-time RT-PCR. Data are presented as the mean ± SEM of three independent experiments. 
membrane and enter the cytoplasm, leading to ap-
optosis. However, Bcl-2 has the opposite function. It 
can counteract the pore-forming activity of Bax and 
prevent the free penetration of small molecules, thus 
protecting the cells from imminent apoptosis [12]. 
This study detected the decreased Bcl-2 expression 
and the increased Bax expression in NSCLC cells 
with miR-1204 overexpression, while the miR-1204 
inhibition showed opposite results in the cells. Hence, 
we presume that the Bcl-2 and Bax proteins were 
involved in the miR-1204-induced apoptosis of A549 
and SPC cells. 
Caspases are intracellular cysteine protease, 
which are capable of inducing apoptosis through 
two major pathways, namely: (i) FADD-caspase-8/3 
and (ii) cytochrome C (CytC)-caspase-9/3 [29].The 
FADD-caspase-8/3 pathway is triggered by Fas/ 
/FasL, while the cytc-caspase-9/3 pathway is triggered 
by mitochondrial damage. Later, caspase-3 (an en-
dogenous endonuclease) is activated, leading to the 
irreversible apoptosis [32, 33]. The activity changes of 
caspase-3, caspase-8, and caspase-9 by colorimetric 
assay in increased apoptosis group were determined. 
The results indicated that the activity of caspase-3 
and caspase-9 were significantly increased, while the 
activity of caspase-8 was not affected by miR-1204. 
Thus, our results suggest that the main mechanism 
by which miR-1204 induced cell apoptosis acted via 
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mitochondria-related CytC-caspase-9/3 pathway and 
not the caspase-8 pathway. 
In summary, there are only a few studies related 
to the role of miRNA in NSCLC, while a better un-
derstanding of miRNA-mediated gene expression 
regulation is needed. Our study is the first to indi-
cate that DEK is negatively regulated by miR-1204 
in two NSCLC cell lines and that miR-1204 could 
promote apoptosis of the NSCLC cells by inhibiting 
the expression of DEK. The mechanism of miR-1204 
induced apoptosis involves down-regulation of Bcl-2 
and up-regulation of Bax expression. Besides, this 
apoptosis is mediated by mitochondria related caspase 
9/3 pathway. However, further in-depth research is 
needed to elucidate the precise mechanisms of these 
effects. 
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